EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Pathogenesis of MASLD and MASH – role of insulin resistance and lipotoxicity

Shalini K Bansal, Meena B Bansal iD

Alimentary Pharmacology & Therapeutics · 2024-06 · 59 (S1)

DOI: 10.1111/apt.17930 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 07.03.2024. Verfasst von Shalini K Bansal und 1 weiteren Autor:innen. Beteiligte Einrichtung: Sidney Kimmel College of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Insulin Resistance. Die Arbeit wurde bisher 186-mal zitiert (Crossref) und nennt 103 Literaturangaben. Gefördert von: NIOSH CDC HHS, MASLD/MASH Center of Excellence at Mount Sinai, Herbert Wreschner Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Insulin resistance and lipotoxicity are extremely interconnected but fundamental in setting the stage for the development of MASLD/MASH. Aim/Methods A comprehensive literature search was performed and key themes were synthesised to provide insight into the underlying molecular mechanisms of insulin resistance and lipotoxicity in the liver, muscle, pancreas and adipose tissue and how organ cross‐talk is fundamental to driving disease pathogenesis.

Results

Classical thinking postulates that excess FFA load exceeds the storage capacity of adipose tissue, which is predicated upon both genetic and environmental factors. This results in insulin resistance and compensatory hyperinsulinaemia by pancreatic beta cells to overcome target organ insulin resistance. As adipocyte dysfunction worsens, not only are excess FFA delivered to other organs, including skeletal muscle, pancreas and liver but a pro‐inflammatory milieu is established with increases in IL‐6, TNF‐α and changes in adipokine levels (increased leptin and decreased adiponectin). With increased intramuscular lipid accumulation, lipotoxic species decrease insulin signalling, reduce glucose uptake by downregulation of GLUT4 and decrease glycogen synthesis. With this additional reduced capacity, hyperglycaemia is further exacerbated and increased FFA are delivered to the liver. The liver has the largest capacity to oxidise fat and to adapt to these stressors and, therefore, has become the last line of defence for excess lipid storage and utilisation, the capacity of which may be impacted by genetic and environmental factors. However, when the liver can no longer keep up with increasing FFA delivery and DNL, lipotoxic species accumulate with ensuing mitochondrial dysfunction, increased ER stress, oxidant stress and inflammasome activation, all of which drive hepatocyte injury and apoptosis. The resulting wound healing response, marked by stellate cell activation, drives collagen accumulation, progressive fibrosis, and, ultimately, end organ failure and death. This vicious cycle and complex interplay between insulin resistance, hyperinsulinaemia, lipotoxicity and multi‐directional cross‐talk among different target organs are critical drivers of MASLD/MASH.

Conclusions

Targeting tissue‐specific insulin resistance and hyperinsulinaemia while decreasing FFA load (lipotoxicity) through dietary and lifestyle changes remain the best upstream interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceHumansAdipose TissueLipid MetabolismMuscle, SkeletalLiver

Autor:innen und Institutionen

  • Sidney Kimmel College of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

ORCID-Profile: Meena B Bansal

Förderung

  • NIOSH CDC HHS
  • MASLD/MASH Center of Excellence at Mount Sinai
  • Herbert Wreschner Fund
  • NIH
  • Pfizer
  • the Kinetix Group
  • Histoindex
  • National Institutes of Health

Zitieren

APA

Bansal, S. K., & Bansal, M. B. (2024). Pathogenesis of MASLD and MASH – role of insulin resistance and lipotoxicity. Alimentary Pharmacology & Therapeutics, 59(S1). https://doi.org/10.1111/apt.17930

Vancouver

Bansal SK, Bansal MB. Pathogenesis of MASLD and MASH – role of insulin resistance and lipotoxicity. Alimentary Pharmacology & Therapeutics. 2024;59(S1). doi:10.1111/apt.17930

BibTeX
@article{Bansal2024,
  author = {Bansal, Shalini K and Bansal, Meena B},
  title = {Pathogenesis of MASLD and MASH – role of insulin resistance and lipotoxicity},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2024},
  volume = {59},
  number = {S1},
  doi = {10.1111/apt.17930}
}
Kostenlos starten →